By Marc Lallanilla Published Oct. 12, 2023, 5:00 p.m HEART DISEASETrans women taking hormones nearly 95% more likely to suffer heart disease, study showsWhy fish oil supplements are basically worthless: studyThis simple activity cuts heart disease risk by 20% — and may beat ‘steps’: studyWeed makes you crazy and gives you heart disease. Why’s it legal?A...
Author: admin
Derby: New anti-viral drug study aims to cure long Covid
IMAGE SOURCE,GETTY IMAGESLong Covid symptoms include extreme fatigue and breathlessness, palpitations, or brain fogBy Sonia KatariaBBC NewsA team of experts have started a new trial to test if an anti-viral drug could cure people with “long Covid”. The University of Derby is leading the £1.2m study that involves about 100 people who have lived with...
AI is coming to mental health care in the U.S., aiming to stretch therapists’ work and make it more effective
“It just feels like I’m talking to somebody who cares.” LIMBIC CEO ROSS HARPER ON THE COMPANY’S THERAPY CHATBOT AI is coming to mental health care in the U.S., aiming to stretch therapists’ work and make it more effective. Psychotherapy company Limbic, which already works with the U.K.’s National Health Service, is bringing its AI...
Rare ‘flesh-eating’ bacterium spreads North as oceans warm
Reviewed by Megan Craig, M.Sc.Oct 13 2023Debbie King barely gave it a second thought when she scraped her right shin climbing onto her friend’s pontoon for a day of boating in the Gulf of Mexico on Aug. 13. Even though her friend immediately dressed the slight cut, her shin was red and sore when King...
How to treat diarrhea at home
People can take steps to stop or help diarrhea at home, including over-the-counter (OTC) medications, such as loperamide (Imodium), and avoiding foods that may worsen symptoms. Diarrhea is a digestive problem that causes loose, watery bowel movements. It typically lastsTrusted Source for less than a couple of weeks. However, chronic diarrhea can occur if symptoms...
AI Tool Reveals MS Drug Interactions, Offers Safer Options
Liam Davenport October 12, 2023 MILAN — A form of artificial intelligence that compares the structures of drugs and foods found numerous potential interactions in patients with multiple sclerosis, and made suggestions for less risky therapeutic combinations, German researchers are reporting. The team fed the medication plans of almost 630 patients into a deep neural network, which...
Bone Degradation Measure Can Sway Osteoporosis Diagnosis
Jake Remaly October 12, 2023 Assessing a key aspect of bone architecture, for which clinicians can now be reimbursed under Medicare, can significantly improve the ability to predict a patient’s risk for bone fracture. Although bone mineral density (BMD) is traditionally used to identify patients with osteoporosis or low bone mass, some physicians have begun incorporating the...
CBT Linked to Reduced Pain, Less Catastrophizing in Fibromyalgia
Pauline Anderson October 02, 2023 TOPLINE:In patients with fibromyalgia, cognitive behavior therapy (CBT) can reduce pain through its effect on pain-related catastrophizing, which involves intensified cognitive and emotional responses to things like intrusive thoughts, a new study suggests. METHODOLOGY:The study included 98 female patients with fibromyalgia (FM), mean age about 42 years, who underwent a baseline neuroimaging...
What does green, yellow, or brown phlegm mean?
Problems in the lungs can cause phlegm to change color. Green or yellow phlegm can occur with an infection, but brown phlegm might indicate bleeding in the lungs. Phlegm is a type of mucus that comes from the lungs and respiratory tract. Typically, phlegm is clear, thin, and unnoticeable. When someone has a cold or...
GLP-1 Agonists and Suicide Risk: What Action Should Be Taken?
Boris Hansel, MD, PhD A statement from the European Medicines Agency (EMA) about semaglutide and, more generally, glucagon-like peptide 1 (GLP-1) agonists recently caused a stir. Could these medicines lead to patients taking their own lives? Medical Authorities AlertThe EMA published a press release in early July 2023 to announce that a review is underway...